Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Powles

Showing results (41-50 of 275) with videos related to

Pageof 28
Sort By:
Drug Safety|January 1, 1994
Tamoxifen in the prevention of breast cancer. Are the risks likely to outweigh the benefits?M O'Brien, T J Powles
Lancet (London, England)|May 29, 1993
Screening of inherited breast cancer with DNA markersT J Powles, M Baum
Lancet (London, England)|June 3, 1995
Breast cancer response to hormone replacement therapy withdrawalT J Powles, T Hickish
Lancet (London, England)|April 16, 1994
Endometrial cancer during tamoxifen treatmentT J Powles, S Ashley
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Chemoprevention options for BRCA1 and BRCA2 mutation carriersR A Eeles, T J Powles
Lancet (London, England)|December 16, 1978
Multimodal therapy for stage-II breast cancerI E Smith, T J Powles
Australian and New Zealand Journal of Public Health|May 26, 1998
The Australian mortality decline: all-cause mortality 1788-1990R Taylor, M Lewis, J Powles
Australian and New Zealand Journal of Public Health|May 26, 1998
The Australian mortality decline: cause-specific mortality 1907-1990R Taylor, M Lewis, J Powles
Cancer Treatment Reviews|June 1, 1979
Non-steroidal anti-inflammatory drugs and cytotoxicsT J Powles, J L Millar
Oncology|April 1, 1993
MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancerI E Smith, T J Powles
Pageof 28

Showing results (41-50 of 275) with videos related to

Sort By:
Pageof 28
Drug Safety|January 1, 1994
Tamoxifen in the prevention of breast cancer. Are the risks likely to outweigh the benefits?M O'Brien, T J Powles
Lancet (London, England)|May 29, 1993
Screening of inherited breast cancer with DNA markersT J Powles, M Baum
Lancet (London, England)|June 3, 1995
Breast cancer response to hormone replacement therapy withdrawalT J Powles, T Hickish
Lancet (London, England)|April 16, 1994
Endometrial cancer during tamoxifen treatmentT J Powles, S Ashley
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Chemoprevention options for BRCA1 and BRCA2 mutation carriersR A Eeles, T J Powles
Lancet (London, England)|December 16, 1978
Multimodal therapy for stage-II breast cancerI E Smith, T J Powles
Australian and New Zealand Journal of Public Health|May 26, 1998
The Australian mortality decline: all-cause mortality 1788-1990R Taylor, M Lewis, J Powles
Australian and New Zealand Journal of Public Health|May 26, 1998
The Australian mortality decline: cause-specific mortality 1907-1990R Taylor, M Lewis, J Powles
Cancer Treatment Reviews|June 1, 1979
Non-steroidal anti-inflammatory drugs and cytotoxicsT J Powles, J L Millar
Oncology|April 1, 1993
MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancerI E Smith, T J Powles
Pageof 28